Exploring redox vulnerabilities in JAK2V617F-positive cellular models (2021)
- Authors:
- USP affiliated authors: LOPES, LUCIA ROSSETTI - ICB ; MACHADO NETO, JOÃO AGOSTINHO - ICB ; LIMA, KELI CRISTINA DE - FM
- Unidades: ICB; FM
- DOI: 10.1016/j.htct.2020.08.006
- Subjects: FARMACOLOGIA; NEOPLASIAS; CÉLULAS CULTIVADAS DE TUMOR; APOPTOSE; CITOMETRIA DE FLUXO; REAÇÃO EM CADEIA POR POLIMERASE; WESTERN BLOTTING
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Publisher place: Sao José do Rio Preto, SP
- Date published: 2021
- Source:
- Título: Hematology, Transfusion and Cell Therapy
- ISSN: 2531-1387
- Volume/Número/Paginação/Ano: v. 43, n. 4, p. 430-436, 2021
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
LIMA, Keli e LOPES, Lucia Rossetti e MACHADO NETO, João Agostinho. Exploring redox vulnerabilities in JAK2V617F-positive cellular models. Hematology, Transfusion and Cell Therapy, v. 43, n. 4, p. 430-436, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.htct.2020.08.006. Acesso em: 12 fev. 2026. -
APA
Lima, K., Lopes, L. R., & Machado Neto, J. A. (2021). Exploring redox vulnerabilities in JAK2V617F-positive cellular models. Hematology, Transfusion and Cell Therapy, 43( 4), 430-436. doi:10.1016/j.htct.2020.08.006 -
NLM
Lima K, Lopes LR, Machado Neto JA. Exploring redox vulnerabilities in JAK2V617F-positive cellular models [Internet]. Hematology, Transfusion and Cell Therapy. 2021 ; 43( 4): 430-436.[citado 2026 fev. 12 ] Available from: https://doi.org/10.1016/j.htct.2020.08.006 -
Vancouver
Lima K, Lopes LR, Machado Neto JA. Exploring redox vulnerabilities in JAK2V617F-positive cellular models [Internet]. Hematology, Transfusion and Cell Therapy. 2021 ; 43( 4): 430-436.[citado 2026 fev. 12 ] Available from: https://doi.org/10.1016/j.htct.2020.08.006 - Synthesis and evaluation of 2-substituted quinazolin-4(3H)-ones as potential antileukemic agents
- In Silico, in vitro, and in vivo studies of a 2-substituted quinazolin-4(3H)-one in T-cell acute lymphoblastic leukemia
- Protein dsulfide isomerase: a novel therapeutic target for melanoma chemotherapy resistance
- miRNAs as prognostic predictors in acute myeloid leukemia [Editorial]
- Regulation of NAD(P)H oxidase by associated protein disulfide isomerase in vascular smooth muscle cells
- Phosphorylated 'p40 POT.PHOX' as a negative regulator of NADPH oxidase
- Endo-PDI is required for TNFα-induced angiogenesis
- Protein disulfide isomerase and Nox: new partners in redox signaling
- Novel role of protein disulfide isomerase in the regulation of NADPH oxidase activity: pathophysiological implications in vascular diseases
- Nox1 in cardiovascular diseases: regulation and pathophysiology
Informações sobre o DOI: 10.1016/j.htct.2020.08.006 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
Exploring_redox_vulnerabi... | Direct link |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
